Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing

Epidemiology and Infection

Volumn 143, Issue 1, 2015, Pages 150-156

  Hongguang, C ^a   Min, L ^a   Shiwen, J ^b   Fanghui, G ^a   Shaoping, H ^c   Tiejie, G ^c   Na, L ^c   Zhiguo, Z ^c  

^a PEKING UNIVERSITY   (China)

^b National Center for Tuberculosis Control and Prevention   (China)

^c PTB Dispensary of Fangshan District   (China)

Author keywords

Infectious disease control; infectious disease epidemiology; tuberculosis (TB)

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE; ARTICLE; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETREATMENT; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME; URBAN AREA; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL; TUBERCULOSIS, PULMONARY; URBAN POPULATION; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; CHINA; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; URBAN POPULATION; YOUNG ADULT;

EID: 84918505851     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881400079X     Document Type: Article

References (29)

1. Lönnroth K, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-1829
2. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367: 938-940
3. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010; 87: 4-14
4. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Research and Clinical Practice 2010; 87: 15-19
5. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 2008; 5: e152
6. Kim SJ, et al. Incidence of pulmonary tuberculosis among diabetics. Tubercle and Lung Disease 1995; 76: 529-533
7. World Health Organization. Global tuberculosis report 2012 (http://www.who.int/tb/publications/global-report/ en/). Accessed 7 April 2013
8. Wang LX, et al. The fifth national tuberculosis epidemiological survey in 2010. Chinese Journal of Antituberculosis 2012; 34: 485-508
9. Alcorn T, Ouyang Y. Diabetes saps health and wealth from China's rise. Lancet 2012; 379: 2227-2228
10. Yang W, et al. Prevalence of diabetes among men and women in China. New England Journal of Medicine 2010; 362: 1090-1101
11. Pablos-Méndez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. American Journal of Public Health 1997; 87: 574-579
12. Mori MA, Leonardson G,Welty TK. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Archives of Internal Medicine 1992; 152: 547-550
13. Alisjahbana B, et al. Diabetes mellitus is strongly associated with tuberculosis in Indonesia. International Journal of Tuberculosis and Lung Disease. 2006; 10: 696-700
14. Leung CC, et al. Diabetic control and risk of tuberculosis: a cohort study. American Journal of Epidemiology 2008; 167: 1486-1494
15. Pérez A, Brown HS 3rd, Restrepo BI. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. American Journal of Tropical Medicine and Hygiene 2006; 74: 604-611
16. Ruslami R, et al. Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health 2010; 15: 1289-1299
17. Baker MA, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review.BMCMedicine 2011; 9: 1-15
18. Alisjahbana B, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious Diseases 2007; 45: 428-435
19. Wang Q, et al. Prevalence of type 2 diabetes among newly detected pulmonary tuberculosis patients in China: a community based cohort study. PLoS One 2013; 8: e82660
20. WHO. Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva:WHO, 1999. Report No.WHO/NCD/NCS/99.2
21. Li L, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Medicine and International Health 2012; 25: 1294-1301
22. Zhang Q, Xiao H, Sugawara I. Tuberculosis complicated by diabetes mellitus at Shanghai pulmonary hospital, China. Japanese Journal of Infectious Diseases 2009; 62: 390-391
23. Yuan MX, et al. A population-based prevalence survey and risk factor analysis of diabetic retinopathy in Changping district of Beijing. Journal of Capital Medical University 2012; 33: 670-676
24. Wang JW, et al. A cross-sectional study of diabetes-hypertension and related cardiovascular complications in people aged 40 years old and above of rural in Fangshan District of Beijing. Chinese Journal of Disease Control and Prevention 2010; 14: 590-593
25. Wallander M, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008; 31: 36-38
26. Jeon CY, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Tropical Medicine and International Health 2010; 15: 1300-1314
27. Ning M, et al. Estimation and projection of HIV/AIDS epidemic infection and treatment demand in Beijing and Hunan province with spectrum. Infection International 2013; 2: 13-24
28. Restrepo BI, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology &Infection 2007; 135: 483-491
29. Wang JY, Lee LN, Hsueh PR. Factors changing the manifestation of pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease 2005; 9: 777-783